The Effects of Acthar on Synovial Inflammation in Rheumatoid Arthritis

Status unconfirmed · Phase 3

Conditions studied: Rheumatoid Arthritis

In brief

Patients will be assigned to receive either Depo Medrol or Acthar treatment. A synovial biopsy, blood draws, synovial fluid aspiration, and physician assessments will be performed before and after initiating treatment.

Key facts

Study ID
NCT03511625
Run by
Attune Health Research, Inc.
People needed
6
Starts
2018-10-02
Expected to finish
2024-12-03
Last updated by the study team
2024-01-30

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.